Sacubitril‐Valsartan in a routine community population: attention to volume status critical to achieving target dose-Reference-Cited by-同舟云学术

Sacubitril‐Valsartan in a routine community population: attention to volume status critical to achieving target dose

Published:2020-01-05 Issue:1 Volume:7 Page:159-167
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Pharithi Rebabonye B.¹²^ORCID,Ferre‐Vallverdu Maria¹,Maisel Alan S.³,O'Connell Eoin¹,Walshe Myra¹,Sweeney Claire¹,Barton James¹,McDonald Kathrine²,O'Hare Daniel¹,Watson Chris²⁴,Gallagher Joe¹,Ledwidge Mark¹²,McDonald Kenneth¹²

Affiliation:

1. Heart Failure Unit St. Vincent University Hospital Health Care Group Elm Park Dublin DO4 T6F4 Ireland

2. University College Dublin Belfield Dublin Ireland

3. Division of Cardiovascular Medicine, Coronary Care Unit and Heart Failure Programme, Veterans Affairs San Diego Healthcare System University of San Diego San Diego USA CA

4. Centre for Experimental Medicine Queen's University Belfast Northern Ireland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12547

Reference35 articles.

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

2. Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy

3. Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure

4. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure

5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Aging on Outcomes of Sacubitril/Valsartan in Hypertensive Patients with Heart Failure: A Multicenter Retrospective Study;The Anatolian Journal of Cardiology;2024

2. Risk stratification for worsening renal function and renal decline in heart failure patients with reduced ejection fraction after sacubitril/valsartan treatment;Journal of Cardiology;2023-12

3. Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction;The Korean Journal of Internal Medicine;2023-09-01

4. Combined Left Ventricular Ejection Fraction and N-Terminal pro-B-type Natriuretic Peptide after Sacubitril/Valsartan for Predicting Outcomes in Patients with Heart Failure with Reduced Ejection Fraction;ACTA CARDIOL SIN;2023

5. The Worsening Renal Perfusion Index Predicts the Prognoses of Heart Failure Patients Treated with Sacubitril/Valsartan;Cardiorenal Medicine;2023